Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus Erythematosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT06297408
What this trial is testing

Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology Co., Ltd. 24
Not applicableLooking for participantsNCT06948110
What this trial is testing

Deciphering the Genetic Architecture of Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
National Human Genome Research Institute (NHGRI) 300
Early research (Phase 1)Study completedNCT02391259
What this trial is testing

Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Amgen 57
Early research (Phase 1)Not Yet RecruitingNCT07408908
What this trial is testing

Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of ACT100 in Healthy Participants..

Who this might be right for
Systemic Lupus ErythematosusCutaneous Lupus Erythematosus
Xiamen Amoytop Biotech Co., Ltd. 48
Not applicableStudy completedNCT01060410
What this trial is testing

Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment

Who this might be right for
Lupus Erythematosus, SystemicAdverse Effects
Sun Yat-sen University 222
Large-scale testing (Phase 3)Study completedNCT00424476
What this trial is testing

Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)

Who this might be right for
Systemic Lupus Erythematosus
Human Genome Sciences Inc. 865
Not applicableNot Yet RecruitingNCT06641427
What this trial is testing

Different Aspects and Etiologies of Gastointestinal Bleeding in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Assiut University 47
Testing effectiveness (Phase 2)Study completedNCT01379573
What this trial is testing

Preventive Approach to Congenital Heart Block With Hydroxychloroquine

Who this might be right for
Congenital Heart BlockNeonatal LupusAutoantibody-Associated Heart Block
NYU Langone Health 74
Not applicableLooking for participantsNCT03138941
What this trial is testing

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

Who this might be right for
Systemic Lupus Erythematosus
Monash University 5,000
Not applicableUnknownNCT06327724
What this trial is testing

Belimumab in SLE Synovial Inflammation and Lymph Nodes

Who this might be right for
Systemic Lupus Erythematosus
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 15
Testing effectiveness (Phase 2)Study completedNCT00979654
What this trial is testing

Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Who this might be right for
Systemic Lupus Erythematosus
MedImmune LLC 118
Not applicableLooking for participantsNCT00756769
What this trial is testing

Systemic Lupus Erythematosus in Gullah Health

Who this might be right for
Systemic Lupus Erythematosus
Medical University of South Carolina 750
Large-scale testing (Phase 3)Ended earlyNCT00111306
What this trial is testing

Study of Epratuzumab in Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
UCB Pharma 510
Early research (Phase 1)UnknownNCT05846347
What this trial is testing

Phase I Clinical Study of GC012F Injection in Treatment of Refractory Systemic Lupus Erythematosus

Who this might be right for
CAR-T
Zhejiang University 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721363
What this trial is testing

Obinutuzumab for Systemic Lupus Erythematosus Pure Membranous Nephropathy: a Phase II Trial

Who this might be right for
Lupus NephritisMembranous Nephropathy
Assistance Publique - Hôpitaux de Paris 65
Large-scale testing (Phase 3)Ended earlyNCT01773616
What this trial is testing

Trial of Rituximab and Mycophenolate Mofetil Without Oral Steroids for Lupus Nephritis

Who this might be right for
Systemic Lupus Erythematosus, Lupus Nephritis
Imperial College London 24
Very early researchStudy completedNCT02925351
What this trial is testing

Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases

Who this might be right for
Autoimmune DiseaseCrohn DiseaseInflammatory Disorder+3 more
Jonsson Comprehensive Cancer Center 8
Very early researchLooking for participantsNCT06653556
What this trial is testing

LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 34
Early research (Phase 1)Looking for participantsNCT03816345
What this trial is testing

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Who this might be right for
Autoimmune DiseaseCrohn DiseaseDermatomyositis+11 more
National Cancer Institute (NCI) 300
Not applicableStudy completedNCT04440566
What this trial is testing

O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
University Hospital, Bordeaux 50
Next Page